ES2277831T3 - Utilizacion de pirenoxina para la proteccion de tejidos corneales en fotoqueratectomia. - Google Patents

Utilizacion de pirenoxina para la proteccion de tejidos corneales en fotoqueratectomia. Download PDF

Info

Publication number
ES2277831T3
ES2277831T3 ES00911259T ES00911259T ES2277831T3 ES 2277831 T3 ES2277831 T3 ES 2277831T3 ES 00911259 T ES00911259 T ES 00911259T ES 00911259 T ES00911259 T ES 00911259T ES 2277831 T3 ES2277831 T3 ES 2277831T3
Authority
ES
Spain
Prior art keywords
corneal
pyrenoxine
drug
ros
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00911259T
Other languages
English (en)
Spanish (es)
Inventor
Enrico Boldrini
Mario Univ. 'Degli Studi di Firenze Ciuffi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmigea SpA
Original Assignee
Farmigea SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmigea SpA filed Critical Farmigea SpA
Application granted granted Critical
Publication of ES2277831T3 publication Critical patent/ES2277831T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES00911259T 1999-03-17 2000-03-13 Utilizacion de pirenoxina para la proteccion de tejidos corneales en fotoqueratectomia. Expired - Lifetime ES2277831T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM99A0166 1999-03-17
IT1999RM000166A IT1305306B1 (it) 1999-03-17 1999-03-17 Uso della pirenoxina per la protezione dei tessuti corneali ininterventi di fotocheratectomia.

Publications (1)

Publication Number Publication Date
ES2277831T3 true ES2277831T3 (es) 2007-08-01

Family

ID=11406570

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00911259T Expired - Lifetime ES2277831T3 (es) 1999-03-17 2000-03-13 Utilizacion de pirenoxina para la proteccion de tejidos corneales en fotoqueratectomia.

Country Status (10)

Country Link
US (1) US6610686B1 (https=)
EP (1) EP1173255B1 (https=)
JP (1) JP5167499B2 (https=)
AT (1) ATE349244T1 (https=)
AU (1) AU3324100A (https=)
DE (1) DE60032594T2 (https=)
ES (1) ES2277831T3 (https=)
IT (1) IT1305306B1 (https=)
PT (1) PT1173255E (https=)
WO (1) WO2000054757A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655002B2 (en) * 1996-03-21 2010-02-02 Second Sight Laser Technologies, Inc. Lenticular refractive surgery of presbyopia, other refractive errors, and cataract retardation
US9545338B2 (en) 2006-01-20 2017-01-17 Lensar, Llc. System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser
US10842675B2 (en) 2006-01-20 2020-11-24 Lensar, Inc. System and method for treating the structure of the human lens with a laser
US9889043B2 (en) 2006-01-20 2018-02-13 Lensar, Inc. System and apparatus for delivering a laser beam to the lens of an eye
US8500723B2 (en) 2008-07-25 2013-08-06 Lensar, Inc. Liquid filled index matching device for ophthalmic laser procedures
US8480659B2 (en) 2008-07-25 2013-07-09 Lensar, Inc. Method and system for removal and replacement of lens material from the lens of an eye
US8382745B2 (en) 2009-07-24 2013-02-26 Lensar, Inc. Laser system and method for astigmatic corrections in association with cataract treatment
CA2769090A1 (en) 2009-07-24 2011-01-27 Lensar, Inc. System and method for providing laser shot patterns to the lens of an eye
US8758332B2 (en) 2009-07-24 2014-06-24 Lensar, Inc. Laser system and method for performing and sealing corneal incisions in the eye
US8617146B2 (en) 2009-07-24 2013-12-31 Lensar, Inc. Laser system and method for correction of induced astigmatism
WO2011011788A1 (en) 2009-07-24 2011-01-27 Lensar, Inc. System and method for performing ladar assisted procedures on the lens of an eye
CN102843955A (zh) 2010-02-01 2012-12-26 雷萨公司 眼科应用中吸环基于浦肯野图像的对准
USD694890S1 (en) 2010-10-15 2013-12-03 Lensar, Inc. Laser system for treatment of the eye
USD695408S1 (en) 2010-10-15 2013-12-10 Lensar, Inc. Laser system for treatment of the eye
ES3064580T3 (en) 2010-10-15 2026-04-27 Lensar Inc Scan-controlled illumination of structures within an eye
US10463541B2 (en) 2011-03-25 2019-11-05 Lensar, Inc. System and method for correcting astigmatism using multiple paired arcuate laser generated corneal incisions
EP2800812A1 (en) * 2012-01-04 2014-11-12 Quark Pharmaceuticals, Inc. Double-stranded rna compounds to casp2 and uses thereof
CN103211754A (zh) * 2012-01-19 2013-07-24 武汉诺安药业有限公司 无菌稳定的吡诺克辛钠滴眼液的生产方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2181788A1 (en) * 1994-01-21 1995-07-27 Jonathan Javitt Cis-hydroxyproline analogs for eye treatment
WO1998053806A1 (en) * 1997-05-26 1998-12-03 New Vision Co., Ltd. Medicinal compositions for topical administration containing vitamin d and vitamin k
IT1292103B1 (it) * 1997-06-06 1999-01-25 Pharmaconsult S A S Composizioni farmaceutiche topiche contenenti pirfenossone e uso dello stesso nel trattamento di condizioni infiammatorie
CN1291898A (zh) * 1998-02-25 2001-04-18 若素制药株式会社 用于角膜上皮疾病的药物

Also Published As

Publication number Publication date
ATE349244T1 (de) 2007-01-15
EP1173255B1 (en) 2006-12-27
US6610686B1 (en) 2003-08-26
WO2000054757A3 (en) 2001-03-29
IT1305306B1 (it) 2001-05-04
WO2000054757A2 (en) 2000-09-21
DE60032594D1 (de) 2007-02-08
DE60032594T2 (de) 2007-10-11
EP1173255A2 (en) 2002-01-23
PT1173255E (pt) 2007-03-30
ITRM990166A1 (it) 2000-09-17
AU3324100A (en) 2000-10-04
JP5167499B2 (ja) 2013-03-21
JP2002539153A (ja) 2002-11-19

Similar Documents

Publication Publication Date Title
ES2277831T3 (es) Utilizacion de pirenoxina para la proteccion de tejidos corneales en fotoqueratectomia.
Mencucci et al. CoQ10-containing eye drops prevent UVB-induced cornea cell damage and increase cornea wound healing by preserving mitochondrial function
CZ76893A3 (en) Use of plasminogen activator inhibitors for the preparation of medicaments
JP2007512352A (ja) 黄斑変性およびその他の眼科疾患の改善
Zhang et al. Laser-triggered intraocular implant to induce photodynamic therapy for posterior capsule opacification prevention
JP3362501B2 (ja) 角膜障害治療剤
RU2414218C1 (ru) Глазные капли для лечения дистрофических заболеваний и травм глаз
EP0764018A1 (en) Non-steroidal anti-inflammatory ophthalmic suspensions
Keyal et al. Post-vitrectomy cataract acceleration in phakic eyes: a review
KR20070040326A (ko) 백내장, 황반 변성 및 다른 안과 질환의 개선
Brancato et al. Concomitant effect of topical ubiquinone Q10 and vitamin E to prevent keratocyte apoptosis after excimer laser photoablation in rabbits
Jiang et al. Cyclic cell-penetrating peptide-engineered ceria nanoparticles for non-invasive alleviation of ultraviolet radiation-induced cataract
KR20150126021A (ko) 다이피리다몰을 이용하여 눈 장애를 치료하는데 사용하기 위한 조성물
Mansour et al. Cataractogenesis after repeat laser in situ keratomileusis
RU2508123C1 (ru) Фармацевтическая композиция для местного применения при лечении воспалительных заболеваний глаз и способ ее использования
CN116139083A (zh) 一种低浓度阿托品纳米乳剂及其制备方法和应用
Tung et al. Lens hexokinase deactivation by near-UV irradiation
ES2208434T3 (es) Uso de la ubiquinona q10 para un tratamiento local y para la prevencion de las patologias oftamologicas posquirurgicas.
CA2055434A1 (en) Paracetamol-based pharmaceutical composition
RU2434633C2 (ru) Фармацевтические препаративные формы латрункулина
ES2886723A1 (es) Composicion basada en la actividad antioxidante de la enzima superoxido dismutasa y su aplicacion en enfermedades oculares
EP1173207B1 (en) Miotic agents and hypertonic agents containing ophthalmic compositions
ES2253201T3 (es) Preparaciones de liquido de perfusion para operaciones oftalmicas.
Bodaghi et al. Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eyedrops in controlling postoperative inflammation after cataract surgery
RU2577236C1 (ru) Способ лечения заболеваний глаз, сопровождающихся окислительным стрессом